
David Alland MD
Professor, Medicine, UMDNJ-New Jersey Medical School
Join to view full profile
150 Bergen StNewark, NJ 07103
Phone+1 973-972-2179
Fax+1 973-972-6804
Dr. Alland is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 1988 - 1992
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1984 - 1987
Columbia University Vagelos College of Physicians and SurgeonsClass of 1984
Certifications & Licensure
NJ State Medical License 2001 - 2027
VA State Medical License 2017 - 2020
FL State Medical License 2017 - 2019
TX State Medical License 2017 - 2018
NY State Medical License 1986 - 2003
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- A cartridge-based assay for improved detection of multidrug-resistantdirectly from sputum.Paulami Rudra, Heta Parmar, Naranjargal Daivaa, Claire Tran, Anshika Narang
Journal of Clinical Microbiology. 2026-05-13 - 3 citationsStool Processing Methods for Xpert Ultra Testing in Childhood Tuberculosis: A Prospective, Multicountry Accuracy Study.Devan Jaganath, Pamela Nabeta, Mark P Nicol, Robert Castro, Peter Wambi
Clinical Infectious Diseases. 2026-03-17 - 1 citationsDivergent transcriptional regulation of redox-homeostasis and permeability modulate rifampicin tolerance and sensitivity in Mycobacterium tuberculosis.Jees Sebastian, Shuyi Ma, Tige Rustad, Ethan Bustad, Anooja Thomas
Nature Communications. 2025-12-14
Journal Articles
- Bacterial Factors That Predict Relapse After Tuberculosis TherapyDavid Alland, MD, The New England Journal of Medicine
- Bacterial Factors That Predict Relapse After Tuberculosis TherapyDavid Alland, W Henry Boom, The New England Journal of Medicine
Press Mentions
Pfizer, Moderna Shots Safe During in Vitro Fertilization; Healthy Gut Bacteria May Help Prevent Long COVIDJanuary 27th, 2022
This New Testing Kit Can Detect Any COVID-19 Variant in MinutesJanuary 27th, 2022
Pfizer, Moderna Draws Safely During in Vitro Fertilization; Healthy Gut Bacteria May Help Prevent Long COVIDJanuary 26th, 2022
Grant Support
- Identifying drug tolerance mechanisms in Mycobacterium tuberculosis glpK mutants to develop better treatments against drug tolerant persister bacilli.RUTGERS BIOMEDICAL AND HEALTH SCIENCES2026–2031
- FEND-TBRUTGERS BIOMEDICAL AND HEALTH SCIENCES2025–2030
- Transmission Links and Clinical Spectrum of Exhaled Mycobacterium TuberculosisRUTGERS BIOMEDICAL AND HEALTH SCIENCES2025–2030
- FEND-TBRUTGERS BIOMEDICAL AND HEALTH SCIENCES2025–2030
- FEND-TBRUTGERS BIOMEDICAL AND HEALTH SCIENCES2025–2030
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: